These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8355188)

  • 1. Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors.
    Widzowski DV; Cory-Slechta DA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):526-34. PubMed ID: 8355188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the stimulus properties of a pre- vs. a putative postsynaptic dose of quinpirole.
    Cory-Slechta DA; Zuch CL; Fox RA
    Pharmacol Biochem Behav; 1996 Nov; 55(3):423-32. PubMed ID: 8951984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
    Witkin JM; Nichols DE; Terry P; Katz JL
    J Pharmacol Exp Ther; 1991 May; 257(2):706-13. PubMed ID: 1674533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of lisuride revisited: involvement of dopamine D2 receptors.
    Cunningham KA; Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):147-51. PubMed ID: 3553537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats.
    Callahan PM; Cunningham KA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):585-92. PubMed ID: 8355192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY; Asdourian D; Chiodo LA
    Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE; Sutherland JV; Woolverton WL
    Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
    Cory-Slechta DA; Widzowski DV
    Brain Res; 1991 Jul; 553(1):65-74. PubMed ID: 1681979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE; Woolverton WL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA; Pokora MJ; Widzowski DV
    Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys.
    Woolverton WL; Kamien JB; Goldberg LI
    J Pharmacol Exp Ther; 1987 Apr; 241(1):213-7. PubMed ID: 3553538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.
    Callahan PM; Appel JB; Cunningham KA
    Psychopharmacology (Berl); 1991; 103(1):50-5. PubMed ID: 2006243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
    Brog JS; Beinfeld MC
    J Pharmacol Exp Ther; 1992 Jan; 260(1):343-8. PubMed ID: 1346163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.